ATE357935T1 - Verfahren zum erhöhen der zuführung einer therapeutischen nukleinsäure - Google Patents
Verfahren zum erhöhen der zuführung einer therapeutischen nukleinsäureInfo
- Publication number
- ATE357935T1 ATE357935T1 AT02704215T AT02704215T ATE357935T1 AT E357935 T1 ATE357935 T1 AT E357935T1 AT 02704215 T AT02704215 T AT 02704215T AT 02704215 T AT02704215 T AT 02704215T AT E357935 T1 ATE357935 T1 AT E357935T1
- Authority
- AT
- Austria
- Prior art keywords
- nucleic acid
- therapeutic nucleic
- increase delivery
- delivery
- host
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title abstract 4
- 102000039446 nucleic acids Human genes 0.000 title abstract 4
- 108020004707 nucleic acids Proteins 0.000 title abstract 4
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 230000003915 cell function Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 210000001865 kupffer cell Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0083—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the administration regime
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26341601P | 2001-01-22 | 2001-01-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE357935T1 true ATE357935T1 (de) | 2007-04-15 |
Family
ID=23001688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02704215T ATE357935T1 (de) | 2001-01-22 | 2002-01-22 | Verfahren zum erhöhen der zuführung einer therapeutischen nukleinsäure |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7534424B2 (enExample) |
| EP (1) | EP1363676B1 (enExample) |
| JP (1) | JP2005502585A (enExample) |
| AT (1) | ATE357935T1 (enExample) |
| AU (1) | AU2002237910B2 (enExample) |
| CA (1) | CA2435443A1 (enExample) |
| CY (1) | CY1106676T1 (enExample) |
| DE (1) | DE60219142T2 (enExample) |
| DK (1) | DK1363676T3 (enExample) |
| ES (1) | ES2283524T3 (enExample) |
| NZ (1) | NZ527645A (enExample) |
| PT (1) | PT1363676E (enExample) |
| WO (1) | WO2002056918A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6696423B1 (en) * | 1997-08-29 | 2004-02-24 | Biogen, Inc. | Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
| JP4736413B2 (ja) * | 2004-12-14 | 2011-07-27 | 富士ゼロックス株式会社 | 生体分子保持物及び生体分子の保存方法 |
| WO2011074564A1 (ja) * | 2009-12-15 | 2011-06-23 | タカラバイオ株式会社 | アデノウイルスベクターの製造方法 |
| US20140141065A1 (en) * | 2012-11-19 | 2014-05-22 | Discovery Genomics, Inc. | Method to achieve extended expression of dna infused into liver |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3710795A (en) * | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| US4797368A (en) * | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5399346A (en) * | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| US5262564A (en) * | 1992-10-30 | 1993-11-16 | Octamer, Inc. | Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents |
| DE19525900C1 (de) * | 1995-07-15 | 1996-12-12 | Max Planck Gesellschaft | Leberspezifischer Adenovirus-Expressionsvektor |
| US6696423B1 (en) * | 1997-08-29 | 2004-02-24 | Biogen, Inc. | Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
| EA003256B1 (ru) * | 1997-08-29 | 2003-02-27 | Байоджен, Инк. | СПОСОБЫ ЛЕЧЕНИЯ ЗЛОКАЧЕСТВЕННЫХ ОПУХОЛЕЙ IN VIVO ПРИ ПОМОЩИ ГЕНОТЕРАПИИ С ИСПОЛЬЗОВАНИЕМ ГЕНОВ, КОДИРУЮЩИХ β-ИНТЕРФЕРОН |
| US20010031741A1 (en) * | 2000-02-17 | 2001-10-18 | Robin Ziegler | Methods for treatment of lysosomal storage diseases |
-
2002
- 2002-01-22 DE DE60219142T patent/DE60219142T2/de not_active Expired - Fee Related
- 2002-01-22 EP EP02704215A patent/EP1363676B1/en not_active Expired - Lifetime
- 2002-01-22 AU AU2002237910A patent/AU2002237910B2/en not_active Ceased
- 2002-01-22 JP JP2002557425A patent/JP2005502585A/ja active Pending
- 2002-01-22 ES ES02704215T patent/ES2283524T3/es not_active Expired - Lifetime
- 2002-01-22 DK DK02704215T patent/DK1363676T3/da active
- 2002-01-22 PT PT02704215T patent/PT1363676E/pt unknown
- 2002-01-22 NZ NZ527645A patent/NZ527645A/en unknown
- 2002-01-22 WO PCT/US2002/001797 patent/WO2002056918A2/en not_active Ceased
- 2002-01-22 AT AT02704215T patent/ATE357935T1/de not_active IP Right Cessation
- 2002-01-22 CA CA002435443A patent/CA2435443A1/en not_active Abandoned
-
2003
- 2003-07-11 US US10/618,299 patent/US7534424B2/en not_active Expired - Lifetime
-
2007
- 2007-06-25 CY CY20071100841T patent/CY1106676T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1363676E (pt) | 2007-06-22 |
| US20040086486A1 (en) | 2004-05-06 |
| ES2283524T3 (es) | 2007-11-01 |
| AU2002237910B2 (en) | 2007-01-25 |
| DE60219142T2 (de) | 2007-12-13 |
| AU2002237910C1 (en) | 2002-07-30 |
| CY1106676T1 (el) | 2012-05-23 |
| DK1363676T3 (da) | 2007-07-23 |
| EP1363676A2 (en) | 2003-11-26 |
| WO2002056918A3 (en) | 2002-11-14 |
| EP1363676B1 (en) | 2007-03-28 |
| JP2005502585A (ja) | 2005-01-27 |
| US7534424B2 (en) | 2009-05-19 |
| NZ527645A (en) | 2008-10-31 |
| WO2002056918B1 (en) | 2004-04-08 |
| CA2435443A1 (en) | 2002-07-25 |
| DE60219142D1 (de) | 2007-05-10 |
| WO2002056918A2 (en) | 2002-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002006316A3 (en) | Alpha-msh related compounds and methods of use | |
| DE50211110D1 (de) | INJEKTIONSGERÄT FÜR mRNA APPLIKATION | |
| DK0981630T3 (da) | Polypeptider med prolyldipeptidylaminopeptidaseaktivitet og nukleinsyrer, der koder for samme | |
| GB2398220A (en) | Automated foot bath apparatus and method | |
| NO20062080L (no) | Nukleinsyrekonstrukter | |
| LU91680I2 (fr) | "rilonacept et ses dérivés pharmaceutiquement acceptables (ARCALYSR)" | |
| ES2534303T3 (es) | Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN | |
| ATE345682T1 (de) | In vitro verfahren zum einbringen von nukleinsäuren in eine zelle | |
| EA200500019A1 (ru) | Ксиланазы, кодирующие их нуклеиновые кислоты и способы их получения и применения | |
| ATE511655T1 (de) | Verfahren zur auswertung eines myelounterdrückungszustands | |
| ATE521357T1 (de) | Verfahren zur behandlung von hepatitis | |
| DE602004029699D1 (de) | Nukleinsäuren zum auslösen der tumorzellsterblichkeit | |
| WO2000073764A3 (en) | Composition and methods for the therapeutic use of an atonal-associated sequence | |
| WO2004046494A3 (en) | Method using particulate chelates to stimulate production of petroleum in carbonate formations | |
| BR0009472A (pt) | Antagonistas de lhrh com propriedades desolubilidade aperfeiçoadas | |
| DE60333004D1 (de) | Antikrebsmittel mit verotoxinvarianten | |
| ES2131612T3 (es) | Oligomeros de union a acidos nucleicos con ramificacion en c para terapia y diagnostico. | |
| DE60335497D1 (de) | Ergillus-phytasen | |
| DE60219142D1 (de) | Verfahren zum erhöhen der zuführung einer therapeutischen nukleinsäure | |
| DE69840637D1 (de) | Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen | |
| BR0009775A (pt) | Método para melhorar a migração e invasão de mioblastos no contexto de terapia genética | |
| WO2006020949A3 (en) | Combined gene therapy for the treatment of macroscopic gliomas | |
| DE69833264D1 (de) | Verfahren und zusammensetzungen für die krebstherapie unter verwendung von interferon-beta codierenden genen | |
| EP1305435A4 (en) | COMPOSITIONS AND METHODS OF USE OF THE HERPES SIMPLEX VIRUS GLYKOPROTEINS-D FOR SUPPRESSING IMMUNE RESPONSES | |
| CY1112512T1 (el) | ΜΕΤΑΛΛΑΓΜΕΝΕΣ ΠΡΩΤΕΪΝΕΣ ΘΕΣΗΣ ΓΛΥΚΟΖΥΛΙΩΣΗΣ ΤIr3 ΚΑΙ ΜΕΘΟΔΟΙ ΧΡΗΣΗΣ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1363676 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |